PMID: 11926349Apr 3, 2002Paper

Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe

Blood Pressure
Lennart HanssonZoe Kopp

Abstract

To estimate the burden of failing to achieve targets for blood pressure (BP) control in France, Germany, Italy, Sweden and the UK. A cost of illness model was constructed to estimate the impact of uncontrolled hypertension to each national healthcare system. Prevalence of uncontrolled hypertension was taken from published data. Relationships between achieved BP and the cardiovascular events of symptomatic acute myocardial infarction, congestive heart failure and stroke were estimated from the HOT study. Costs were taken from public sources. The acute medical costs of these events were estimated at current prevalence of uncontrolled hypertension and if BP were treated to target. The model estimated that 29 million adults in the five countries (13% population) have BP levels above 160/95 mmHg, and an additional 46 million (21% population) have BP in the range 140/90-160/95 mmHg. The model estimated that healthcare system costs of 1.26 billion euros could be avoided if hypertension management did achieve BP targets. This does not consider the cost of interventions required to reduce the risk of cardiovascular disease. Failing to achieve BP targets contributes substantially to healthcare system costs and preventable events in the c...Continue Reading

Citations

Nov 26, 2002·American Journal of Respiratory and Critical Care Medicine·Sabine KonyFrançoise Neukirch
Sep 22, 2011·ClinicoEconomics and Outcomes Research : CEOR·Luca Degli EspostiEzio Degli Esposti
Feb 1, 2003·Expert Review of Pharmacoeconomics & Outcomes Research·Patrizia Berto, Stefania Lopatriello
Apr 1, 2004·Expert Review of Pharmacoeconomics & Outcomes Research·Krista A Payne, J Jaime Caro
Dec 17, 2014·Clinical and Experimental Hypertension : CHE·Kostas AthanasakisJohn Kyriopoulos
Aug 30, 2008·International Journal of Cardiology·Markus LingmanMarianne Hartford
Mar 16, 2004·Progress in Cardiovascular Nursing·Eduardo Sabaté, Sabina De Geest
Feb 1, 2007·International Journal of Clinical Practice·E A Francischetti, V A Genelhu
Jun 29, 2004·Clinical Therapeutics·Giuseppe Mancia
May 2, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Frederick D Richard HobbsUNKNOWN JEWEL Study Group
Jun 4, 2010·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yuichiro TamakiYutaka Imai
Aug 11, 2006·PharmacoEconomics·Renee StarkReiner Leidl
Apr 1, 2009·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·Josep RedonGert van Montfrans
Dec 1, 2009·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Francesco Vittorio CostaStefano Buda
Sep 13, 2006·Journal of Human Hypertension·E MagenJ Mishal
Sep 6, 2005·Cardiovascular Drugs and Therapy·Larus S GudmundssonJacqueline C M Witteman
Mar 22, 2003·PharmacoEconomics·Adam LloydNick Marchant
Mar 22, 2003·PharmacoEconomics·Penny YoumanLalit Kalra
Apr 21, 2010·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Eberhard WilleKerstin Uhl-Hochgraeber
Feb 10, 2012·Journal of Hypertension·Ettore Ambrosioni
Nov 28, 2013·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Giuliano TocciMassimo Volpe
Jul 12, 2017·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Francesco Vittorio Costa
May 1, 2018·The Journal of Laryngology and Otology·O SakalliogluS Duzer
Apr 10, 2010·Central European Journal of Public Health·Anna D Ivanova, Guenka I Petrova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

The Lancet. Diabetes & Endocrinology
Journal of General Internal Medicine
Tracey Delaplain
© 2022 Meta ULC. All rights reserved